Grape Seed Procyanidins and Cholestyramine Differentially Alter Bile Acid and Cholesterol Homeostatic Gene Expression in Mouse Intestine and Liver
Open Access
- 25 April 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (4) , e0154305
Abstract
Bile acid (BA) sequestrants, lipid-lowering agents, may be prescribed as a monotherapy or combination therapy to reduce the risk of coronary artery disease. Over 33% of adults in the United States use complementary and alternative medicine strategies, and we recently reported that grape seed procyanidin extract (GSPE) reduces enterohepatic BA recirculation as a means to reduce serum triglyceride (TG) levels. The current study was therefore designed to assess the effects on BA, cholesterol and TG homeostatic gene expression following co-administration with GSPE and the BA sequestrant, cholestyramine (CHY). Eight-week old male C57BL/6 mice were treated for 4 weeks with either a control or 2% CHY-supplemented diet, after which, they were administered vehicle or GSPE for 14 hours. Liver and intestines were harvested and gene expression was analyzed. BA, cholesterol, non-esterified fatty acid and TG levels were also analyzed in serum and feces. Results reveal that GSPE treatment alone, and co-administration with CHY, regulates BA, cholesterol and TG metabolism differently than CHY administration alone. Notably, GSPE decreased intestinal apical sodium-dependent bile acid transporter (Asbt) gene expression, while CHY significantly induced expression. Administration with GSPE or CHY robustly induced hepatic BA biosynthetic gene expression, especially cholesterol 7α-hydroxylase (Cyp7a1), compared to control, while co-administration further enhanced expression. Treatment with CHY induced both intestinal and hepatic cholesterologenic gene expression, while co-administration with GSPE attenuated the CHY-induced increase in the liver but not intestine. CHY also induced hepatic lipogenic gene expression, which was attenuated by co-administration with GSPE. Consequently, a 25% decrease in serum TG levels was observed in the CHY+GSPE group, compared to the CHY group. Collectively, this study presents novel evidence demonstrating that GSPE provides additive and complementary efficacy as a lipid-lowering combination therapy in conjunction with CHY by attenuating hepatic cholesterol synthesis, enhancing BA biosynthesis and decreasing lipogenesis, which warrants further investigation.Keywords
Funding Information
- National Institute of Food and Agriculture (W3122)
- CONICYT Bicentennial Becas-Chile Scholarship
- University of Nevada, Reno
This publication has 62 references indexed in Scilit:
- Bile Acid Signal-induced Phosphorylation of Small Heterodimer Partner by Protein Kinase Cζ Is Critical for Epigenomic Regulation of Liver Metabolic GenesJournal of Biological Chemistry, 2013
- The Ileal Lipid Binding Protein Is Required for Efficient Absorption and Transport of Bile Acids in the Distal Portion of the Murine Small IntestinePLOS ONE, 2012
- Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expressionLipids in Health and Disease, 2010
- Bile acid transportersJournal of Lipid Research, 2009
- Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid SynthesisJournal of Biological Chemistry, 2009
- Prevention and Treatment of Obesity, Insulin Resistance, and Diabetes by Bile Acid–Binding ResinDiabetes, 2007
- Targeted Deletion of the Ileal Bile Acid Transporter Eliminates Enterohepatic Cycling of Bile Acids in MiceJournal of Biological Chemistry, 2003
- Molecular Cloning and Expression of Rabbit Sterol 12α-HydroxylaseJournal of Biological Chemistry, 1996
- Effect of bile salt-binding resins on the morphology of rat jejunum and colonDigestive Diseases and Sciences, 1980
- 12α-Hydroxylation of 7α-hydroxy-4-cholesten-3-one by a reconstituted system from rat liver microsomesBiochemical and Biophysical Research Communications, 1973